X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
female (10) 10
middle aged (10) 10
adult (9) 9
index medicus (9) 9
male (8) 8
aged (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
chemotherapy (5) 5
hematology (5) 5
oncology (5) 5
young adult (5) 5
adolescent (4) 4
prospective studies (4) 4
transplantation (4) 4
treatment outcome (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cancer (3) 3
hematopoietic stem cell transplantation - methods (3) 3
hodgkin disease - drug therapy (3) 3
immunology (3) 3
multiple myeloma (3) 3
transplantation conditioning - methods (3) 3
aged, 80 and over (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
autologous transplantation (2) 2
bone-marrow-transplantation (2) 2
breast cancer (2) 2
breast neoplasms - immunology (2) 2
breast neoplasms - metabolism (2) 2
breast neoplasms - pathology (2) 2
child (2) 2
conditioning regiment (2) 2
cyclophosphamide - administration & dosage (2) 2
cytokines - blood (2) 2
disease (2) 2
etoposide - administration & dosage (2) 2
etoposide - adverse effects (2) 2
graft survival (2) 2
her2 (2) 2
high-dose chemotherapy (2) 2
high-dose melphalan (2) 2
hodgkin disease - mortality (2) 2
medicine (2) 2
melphalan (2) 2
melphalan - administration & dosage (2) 2
melphalan - adverse effects (2) 2
mortality (2) 2
neoadjuvant therapy (2) 2
neoplasm staging (2) 2
polymorphism, genetic (2) 2
randomized-trial (2) 2
receptor, erbb-2 - metabolism (2) 2
research article (2) 2
risk (2) 2
salvage therapy (2) 2
skin and connective tissue diseases (2) 2
stem cells (2) 2
survival (2) 2
therapy (2) 2
thiotepa (2) 2
transplantation conditioning - adverse effects (2) 2
transplantation, autologous (2) 2
trastuzumab (2) 2
200 mg/m melphalan (1) 1
4th european conference (1) 1
5-ht3 antagonist (1) 1
acute disease (1) 1
acute myeloid-leukemia (1) 1
adapted immunochemotherapy (1) 1
adjuvant trastuzumab (1) 1
adjuvant treatment (1) 1
administration, oral (1) 1
advanced breast-cancer (1) 1
aftercare (1) 1
age factors (1) 1
aml (1) 1
anemia - chemically induced (1) 1
anemia - genetics (1) 1
angina pectoris (1) 1
animals (1) 1
anthracyclines (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, protozoan - blood (1) 1
antibody-dependent cell cytotoxicity - immunology (1) 1
antiemetic therapy (1) 1
antiemetics (1) 1
antiemetics - therapeutic use (1) 1
antigens, cd34 - analysis (1) 1
antigens, neoplasm - chemistry (1) 1
antigens, neoplasm - immunology (1) 1
antigens, protozoan - immunology (1) 1
antilymphocyte serum - administration & dosage (1) 1
antilymphocyte serum - toxicity (1) 1
antimicrobial resistance (1) 1
antineoplastic agents, hormonal - adverse effects (1) 1
antineoplastic agents, hormonal - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - pharmacokinetics (1) 1
antitumor immune responses (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Girmenia, Corrado and Bertaina, Alice and Piciocchi, Alfonso and Perruccio, Katia and Algarotti, Alessandra and Busca, Alessandro and Cattaneo, Chiara and Raiola, Anna Maria and Guidi, Stefano and Iori, Anna Paola and Candoni, Anna and Irrera, Giuseppe and Milone, Giuseppe and Marcacci, Giampaolo and Scimè, Rosanna and Musso, Maurizio and Cudillo, Laura and Sica, Simona and Castagna, Luca and Corradini, Paolo and Marchesi, Francesco and Pastore, Domenico and Alessandrino, Emilio Paolo and Annaloro, Claudio and Ciceri, Fabio and Santarone, Stella and Nassi, Luca and Farina, Claudio and Viscoli, Claudio and Rossolini, Gian Maria and Bonifazi, Francesca and Rambaldi, Alessandro and Capria, Saveria and Bertaina, A and Mastronuzzi, Angela and Pagliara, Daria and Bernaschi, Paola and Amico, Lucia and Carotti, Alessandra and Mencacci, Antonella and Busca, A and Bruno, Benedetto and Costa, Cristina and Passi, Angela and Ravizzola, Giuseppe and Angelucci, Emanuele and Marchese, Anna and Pecile, Patrizia and Candoni, A and Ventura, Giovanna and Fanin, Renato and Scarparo, Claudio and Barbaro, Angelo and Leotta, Salvatore and Marchese, Anna Elisa and Marcacci, G and Becchimanzi, Cristina and Donnarumma, Daniela and Tringali, Stefania and Baldi, Maria Teresa and Scalone, Renato and Cudillo, L and Picardi, Alessandra and Arcese, William and Fontana, Carla and Sica, S and Giammarco, Sabrina and Spanu, Teresa and Castagna, L and Crocchiolo, Roberto and Casari, Erminia and Mussetti, Alberto and Conte, Eutilia and Ensoli, Fabrizio and Miragliotta, Giuseppe and Marone, Piero and Arghittu, Milena and Greco, Raffaella and Forcina, Alessandra and Chichero, Paola and Santarone, S and Di Bartolomeo, Paolo and Fazii, Paolo and Kroumova, Vesselina and Decembrino, Nunzia and Zecca, Marco and Pisapia, Giovanni and Palazzo, Giulia and Lanino, Edoardo and Faraci, Maura and Castagnola, Elio and Bandettini, Roberto and Pastano, Rocco and Sammassimo, Simona and Passerini, Rita and Stefani, Piero Maria and Gherlinzoni, Filippo and Rigoli, Roberto and Prezioso, Lucia and Cambò, Benedetta and ... and GITMO and AMCLI and Gruppo Italiano Trapianto di Midollo Osseo (GITMO) and Associazione Microbiologi Clinici Italiani (AMCLI)
Clinical Infectious Diseases, ISSN 1058-4838, 12/2017, Volume 65, Issue 11, pp. 1884 - 1896
Journal Article
BMC Cancer, ISSN 1471-2407, 12/2014, Volume 14, Issue 1, pp. 954 - 954
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 1932 - 1938
Abstract High-dose melphalan (MEL) is the standard therapy for autologous stem cell transplantation (ASCT) in multiple myeloma (MM), although the optimal... 
Hematology, Oncology and Palliative Medicine | Conditioning regiment | High-dose melphalan | Autologous transplantation | Thiotepa | Multiple myeloma
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 11/2015, Volume 21, Issue 11, pp. 1932 - 1938
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 2/2009, Volume 17, Issue 2, pp. 205 - 209
The objective of this study was to determine the efficacy of palonosetron combined with dexamethasone in prevention of acute and delayed chemotherapy-induced... 
Chemotherapy-induced nausea and vomiting (CINV) | Pain Medicine | Rehabilitation Medicine | Nursing | Medicine & Public Health | Antiemetics | Oncology | 5-HT3 antagonist | Multiple-day chemotherapy | Nursing Management/Nursing Research | Palonosetron | POSTCHEMOTHERAPY NAUSEA | DAY CISPLATIN CHEMOTHERAPY | PHASE-III | RANDOMIZED-TRIAL | ANTIEMETIC THERAPY | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | REHABILITATION | HIGH-DOSE CHEMOTHERAPY | GRANISETRON PLUS DEXAMETHASONE | STEM-CELL TRANSPLANT | Isoquinolines - adverse effects | Prospective Studies | Nausea - chemically induced | Humans | Middle Aged | Dexamethasone - adverse effects | Male | Young Adult | Antineoplastic Agents, Hormonal - adverse effects | Quinuclidines - therapeutic use | Serotonin Antagonists - adverse effects | Antiemetics - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Drug-Related Side Effects and Adverse Reactions | Aged, 80 and over | Adult | Female | Nausea - drug therapy | Vomiting - prevention & control | Quinuclidines - adverse effects | Serotonin Antagonists - therapeutic use | Vomiting - drug therapy | Nausea - prevention & control | Vomiting - chemically induced | Dexamethasone - therapeutic use | Adolescent | Hematologic Neoplasms - drug therapy | Isoquinolines - therapeutic use | Italy | Aged | Chemotherapy | Nausea | Index Medicus
Journal Article
JOURNAL OF CLINICAL MEDICINE, ISSN 2077-0383, 06/2019, Volume 8, Issue 6, p. 877
Background: The ASPIRE (NCT01080391) phase 3 trial showed the efficacy of carfilzomib, lenalidomide and dexamethasone (KRd) triplet for relapse and refractory... 
DIAGNOSED MULTIPLE-MYELOMA | SURVIVAL | DARATUMUMAB | CRITERIA | multiple myeloma | MULTICENTER | BORTEZOMIB | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | PREDNISONE | THERAPY | KRd regimen | salvage therapy | MELPHALAN
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2016, Volume 172, Issue 1, pp. 111 - 121
Summary High‐dose chemotherapy (HDT) with autologous stem cell transplantation is the standard of care for relapsed/refractory (RR) Hodgkin lymphoma (HL).... 
high‐dose chemotherapy | fotemustine | autologous stem cell transplantation | Hodgkin lymphoma | High-dose chemotherapy | Autologous stem cell transplantation | Fotemustine | FDG-PET | fote-mustine | PULMONARY TOXICITY | PROGNOSTIC-FACTORS | BONE-MARROW-TRANSPLANTATION | STEM-CELL-TRANSPLANTATION | BRENTUXIMAB VEDOTIN | PREPARATIVE REGIMENS | RANDOMIZED-TRIAL | CONDITIONING REGIMEN | SALVAGE THERAPY | HEMATOLOGY | high-dose chemotherapy | Drug Evaluation - methods | Hodgkin Disease - diagnostic imaging | Nitrosourea Compounds - administration & dosage | Nitrosourea Compounds - adverse effects | Salvage Therapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Positron-Emission Tomography | Cytarabine - adverse effects | Young Adult | Melphalan - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Registries | Transplantation Conditioning - methods | Child | Organophosphorus Compounds - adverse effects | Etoposide - adverse effects | Kaplan-Meier Estimate | Etoposide - administration & dosage | Graft Survival | Treatment Outcome | Cytarabine - administration & dosage | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Aged | Organophosphorus Compounds - administration & dosage | Hematopoietic Stem Cell Transplantation - methods | Salvage Therapy - methods | Chemotherapy | Lymphomas | Patient outcomes | Stem cells | Cancer | Index Medicus | Research Paper | Haematological Malignancy
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 499 - 499
Abstract PURPOSE: The HD2000 trial compared doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) versus bleomycin, etoposide, doxorubicin,... 
Journal Article
Breast Cancer Research, ISSN 1465-5411, 11/2011, Volume 13, Issue 6, pp. R117 - R117
Journal Article
Journal of geriatric oncology, ISSN 1879-4068, 07/2019
To evaluate activity and safety of obinutuzumab-miniCHOP (Ga101-miniCHOP) combination in older patients with Diffuse Large B-Cell Lymphoma (DLBCL) unfit to... 
Journal Article
Acta Veterinaria Brno, ISSN 0001-7213, 06/2013, Volume 82, Issue 2, pp. 209 - 214
Kidney diseases as protein-losing nephropathies are predisposing conditions for thrombosis/thromboembolism in dogs due to increased blood coagulability. The... 
Hypercoagulability | Viscoelastic technique | Azotemia | Proteinuria | azotemia | viscoelastic technique | VETERINARY SCIENCES | hypercoagulability
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 03/2012, Volume 53, Issue 3, pp. 406 - 410
Abstract Polymorphisms of the Glutathione-S Transferase (GST) family may influence the prognosis in lymphoma patients. We aimed to validate the impact of GSTT1... 
GSTT1 | polymorphism | GSTM1 | prognosis | Hodgkin's lymphoma | Prognosis | Polymorphism | SUSCEPTIBILITY | RISK | ACUTE MYELOID-LEUKEMIA | CANCER | CHEMOTHERAPY | GENOTYPES | THERAPY | ONCOLOGY | DISEASE | HEMATOLOGY | ASSOCIATION | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Humans | Middle Aged | Biotransformation - genetics | Male | Carboplatin - pharmacokinetics | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Carboplatin - adverse effects | Anemia - genetics | Glutathione Transferase - physiology | Gene Deletion | Hodgkin Disease - mortality | Vincristine - administration & dosage | Neoplasm Proteins - genetics | Glutathione S-Transferase pi - genetics | Dacarbazine - administration & dosage | Genetic Predisposition to Disease | Prednisone - adverse effects | Anemia - chemically induced | Carboplatin - administration & dosage | Etoposide - administration & dosage | Genotype | Bleomycin - administration & dosage | Doxorubicin - pharmacokinetics | Polymorphism, Genetic | Lomustine - pharmacokinetics | Procarbazine - adverse effects | Vincristine - adverse effects | Cyclophosphamide - pharmacokinetics | Lomustine - administration & dosage | Epirubicin - adverse effects | Etoposide - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Hodgkin Disease - genetics | Lomustine - adverse effects | Neoplasm Proteins - physiology | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bleomycin - pharmacokinetics | Epirubicin - administration & dosage | Glutathione S-Transferase pi - physiology | Hodgkin Disease - enzymology | Vinblastine - pharmacokinetics | Glutathione Transferase - genetics | Vinblastine - adverse effects | Vindesine - adverse effects | Hodgkin Disease - drug therapy | Adult | Dacarbazine - pharmacokinetics | Female | Vindesine - pharmacokinetics | Vincristine - pharmacokinetics | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Treatment Outcome | Bleomycin - adverse effects | Procarbazine - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Prednisone - pharmacokinetics | Vindesine - administration & dosage | Epirubicin - pharmacokinetics | Polymorphism, Single Nucleotide | Doxorubicin - adverse effects | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 11, pp. 5286 - 5286
Abstract Cytomegalovirus (CMV) is an important cause of morbidity and mortality in patients who have undergone severe immunosuppressive therapy. Ganciclovir... 
Journal Article
Blood, ISSN 0006-4971, 11/2007, Volume 110, Issue 11, pp. 4460 - 4460
Abstract Meningeal recurrence in aggressive NHL and ALL occurs in up to 20% of patients and mostly depends on intensity and efficacy of front-line CNS... 
Journal Article
Blood, ISSN 0006-4971, 11/2007, Volume 110, Issue 11, pp. 3429 - 3429
Abstract In 2003 the IIL started a randomized trial for the initial treatment of elderly patients with B-DLCL with the aim of comparing efficacy of standard... 
Journal Article